Humalog and Fungizone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Fungizone (amphotericin b). Common drug interactions include cardio-respiratory arrest among females and cerebral toxoplasmosis among males.
The phase IV clinical study analyzes what interactions people have when they take Humalog and Fungizone. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
What is Fungizone?
Fungizone has active ingredients of amphotericin b. eHealthMe is studying from 4,456 Fungizone users. Check the latest studies of Fungizone.
65 people who take Humalog and Fungizone together, and have interactions are studied.

What are the common drug interactions of Humalog and Fungizone, by gender? *:
female:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Hypoproteinaemia (too little prolactin circulating in the blood)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Pancreatitis haemorrhagic (inflammation of pancreas with bleeding)
- Pleural effusion (water on the lungs)
- Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
- Pulmonary congestion (congestion in the lungs)
- Alanine aminotransferase increased
male:
- Cerebral toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Anaemia (lack of blood)
- Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Dyspnoea (difficult or laboured respiration)
- Hepatocellular injury (liver injury)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Malaise (a feeling of general discomfort or uneasiness)
- Purpura (purplish discoloration of the skin)
What are the common drug interactions of Humalog and Fungizone, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Abdominal pain
- Hepatocellular damage (liver damage)
- Hepatomegaly (abnormal enlargement of the liver)
- Liver fatty (fat deposition of liver)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Blood amylase increased
- Cardiovascular disorder (heart diseases)
- Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
20-29:
- Constipation
- Herpes zoster
- Maternal exposure during pregnancy (use of substance during pregnancy)
- Placental insufficiency
- Premature labour
30-39:
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Hepatocellular injury (liver injury)
- Vomiting
40-49:
- Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
- Pyrexia (fever)
- Renal disorder (kidney disease)
- Liver disorder (liver diseases)
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Haematoma (collection of blood outside the blood vessels)
- Scar
- Urinary tract infection
- Anaemia (lack of blood)
50-59:
- Confusional state
- Dyspnoea (difficult or laboured respiration)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
- Hypertension (high blood pressure)
- Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
- Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
- Mucosal inflammation (infection of mucous membrane)
- Oliguria (not enough urine)
60+:
- Cerebral toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Asthenia (weakness)
- Bk virus infection
- Blood uric acid increased
- Erythrosis (reddish or purplish discoloration of the skin and mucous membranes)
- Hypercalcaemia (elevated calcium (ca+) level in the blood)
- Leukocyturia (presence of white blood cells in urine)
- Pruritus (severe itching of the skin)
- Urinary tract infection
What are the existing conditions these people have? *
- Insomnia (sleeplessness): 18 people, 27.69%
- High Blood Pressure: 16 people, 24.62%
- Gout (uric acid crystals building up in the body): 15 people, 23.08%
- Pain: 9 people, 13.85%
- High Blood Cholesterol: 8 people, 12.31%
- Anaemia (lack of blood): 8 people, 12.31%
- Arterial Disorder: 8 people, 12.31%
- Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 8 people, 12.31%
- Enlarged Prostate: 8 people, 12.31%
- Epstein-Barr Virus Infection: 8 people, 12.31%
* Approximation only. Some reports may have incomplete information.
Do you take Humalog and Fungizone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Humalog and Fungizone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fungizone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fungizone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin lispro recombinant and amphotericin b (the active ingredients of Humalog and Fungizone, respectively), and Humalog and Fungizone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Innohep and Pentacarinat - a second ago
- Could Cosopt cause Stable Angina? - 2 seconds ago
- Agitation and High Blood Cholesterol - 2 seconds ago
- Drug interactions of Ceftin and Hyzaar - 5 seconds ago
- Cough and Blood Creatinine Increased - 9 seconds ago
- Could Premarin cause Respiratory Rate Increased? - 10 seconds ago
- Lung Adenocarcinoma and Blood Creatinine Increased - 12 seconds ago
- Could Premarin cause Retinal Disorder? - 12 seconds ago
- Malignant Melanoma and Blood Creatinine Increased - 14 seconds ago
- Could Morphine cause Photosensitivity Reaction? - 22 seconds ago